In vitro circulation model driven by tissue-engineered dome-shaped cardiac tissue

被引:3
|
作者
Kikuchi, Tetsutaro [1 ]
Matsuura, Katsuhisa [1 ]
Shimizu, Tatsuya [1 ]
机构
[1] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
关键词
cell sheet technology; induced pluripotent stem cell; cardiomyocyte; tissue engineering; organ on a chip; drug screening; CELL-DERIVED CARDIOMYOCYTES; RISK-ASSESSMENT; CONSTRUCTION; FABRICATION; MATURATION; PLATFORM; COLLAGEN;
D O I
10.1088/1758-5090/ac77c1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The heart is an essential organ for animals and humans. With the increased availability of pluripotent stem cells, the use of three-dimensional cardiac tissues consisting of cultured cardiomyocytes in in vitro drug evaluation has been widely studied. Several models have been proposed for the realization of the pump function, which is the original function of the heart. However, there are no models that simulate the human circulatory system using cultured cardiac tissue. This study shows that a dome-shaped cardiac tissue fabricated using the cell sheet stacking technique can achieve a heart-like pump function and circulate culture medium, there by mimicking the human circulatory system. Firstly, human induced pluripotent stem cells were differentiated into autonomously beating cardiomyocytes, and cardiomyocyte cell sheets were created using temperature-responsive culture dishes. A cardiomyocyte sheet and a human dermal fibroblast sheet were stacked using a cell sheet manipulator. This two-layered cell sheet was then inflated to create a dome-shaped cardiac tissue with a base diameter of 8 mm. The volume of the dome-shaped cardiac tissue changed according to the autonomous beating. The stroke volume increased with the culture period and reached 21 +/- 8.9 mu l (n = 6) on day 21. It also responded to beta-stimulant and extracellular calcium concentrations. Internal pressure fluctuations were also recorded under isovolumetric conditions by dedicated culture devices. The peak heights of pulsatile pressure were 0.33 +/- 0.048 mmHg (n = 3) under a basal pressure of 0.5 mmHg on day 19. When the tissue was connected to a flow path that had check valves applied, it drove a directional flow with an average flow rate of approximately 1 mu l s(-1). Furthermore, pressure-volume (P-V) diagrams were created from the simultaneous measurement of changes in pressure and volume under three conditions of fluidic resistance. In conclusion, this cardiac model can potentially be used for biological pumps that drive multi-organ chips and for more accurate in vitro drug evaluation using P-V diagrams.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] An in vitro tissue-engineered model for osteochondral repair
    Peretti G.M.
    Buragas M.
    Scotti C.
    Mangiavini L.
    Sosio C.
    Giancamillo A.
    Domeneghini C.
    Fraschini G.
    Sport Sciences for Health, 2006, 1 (4) : 153 - 157
  • [2] In vitro study of bioactivity of homemade tissue-engineered periosteum
    Zhao, Lin
    Zhao, Junli
    Yu, Jiajia
    Zhao, Xiaofei
    Chen, Qi
    Huang, Yanfeng
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2016, 58 : 1170 - 1176
  • [3] Cardiac Tissue Slice Transplantation as a Model to Assess Tissue-Engineered Graft Thickness, Survival, and Function
    Riegler, Johannes
    Gillich, Astrid
    Shen, Qi
    Gold, Joseph D.
    Wu, Joseph C.
    CIRCULATION, 2014, 130 (11) : S77 - +
  • [4] Cell-based cardiac pumps and tissue-engineered ventricles
    Khait, L.
    Birla, Ravi K.
    REGENERATIVE MEDICINE, 2007, 2 (04) : 391 - 406
  • [5] Frequency-Dependence of Mechanically Stimulated Osteoblastic Calcification in Tissue-Engineered Bone In Vitro
    Tanaka, Shigeo M.
    Tachibana, Kohei
    ANNALS OF BIOMEDICAL ENGINEERING, 2015, 43 (09) : 2083 - 2089
  • [6] Tissue-Engineered Heart Valve: Future of Cardiac Surgery
    Radoslaw A. Rippel
    Hossein Ghanbari
    Alexander M. Seifalian
    World Journal of Surgery, 2012, 36 : 1581 - 1591
  • [7] Spatiotemporal tracking of cells in tissue-engineered cardiac organoids
    Iyer, Rohin K.
    Chui, Jane
    Radisic, Milica
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 3 (03) : 196 - 207
  • [8] Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation
    Koch, Sabine
    Flanagan, Thomas C.
    Sachweh, Joerg S.
    Tanios, Fadwa
    Schnoering, Heike
    Deichmann, Thorsten
    Ella, Ville
    Kellomaki, Minna
    Gronloh, Nina
    Gries, Thomas
    Tolba, Rene
    Schmitz-Rode, Thomas
    Jockenhoevel, Stefan
    BIOMATERIALS, 2010, 31 (17) : 4731 - 4739
  • [9] In vitro tissue-engineered adipose constructs for modeling disease
    Connor S. Murphy
    Lucy Liaw
    Michaela R. Reagan
    BMC Biomedical Engineering, 1 (1):
  • [10] Hypothermic and cryogenic preservation of cardiac tissue-engineered constructs
    Janssen, Jasmijn
    Chirico, Nino
    Ainsworth, Madison J.
    Cedillo-Servin, Gerardo
    Viola, Martina
    Dokter, Inge
    Vermonden, Tina
    Doevendans, Pieter A.
    Serra, Margarida
    Voets, Ilja K.
    Malda, Jos
    Castilho, Miguel
    van Laake, Linda W.
    Sluijter, Joost P. G.
    Sampaio-Pinto, Vasco
    van Mil, Alain
    BIOMATERIALS SCIENCE, 2024, 12 (15) : 3866 - 3881